Razavi Morteza, Leigh Anderson N, Pope Matthew E, Yip Richard, Pearson Terry W
SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, USA.
SISCAPA Assay Technologies, Inc., Box 53309, Washington, DC 20009, USA.
N Biotechnol. 2016 Sep 25;33(5 Pt A):494-502. doi: 10.1016/j.nbt.2015.12.008. Epub 2016 Jan 6.
Efficient robotic workflows for trypsin digestion of human plasma and subsequent antibody-mediated peptide enrichment (the SISCAPA method) were developed with the goal of improving assay precision and throughput for multiplexed protein biomarker quantification. First, an 'addition only' tryptic digestion protocol was simplified from classical methods, eliminating the need for sample cleanup, while improving reproducibility, scalability and cost. Second, methods were developed to allow multiplexed enrichment and quantification of peptide surrogates of protein biomarkers representing a very broad range of concentrations and widely different molecular masses in human plasma. The total workflow coefficients of variation (including the 3 sequential steps of digestion, SISCAPA peptide enrichment and mass spectrometric analysis) for 5 proteotypic peptides measured in 6 replicates of each of 6 different samples repeated over 6 days averaged 3.4% within-run and 4.3% across all runs. An experiment to identify sources of variation in the workflow demonstrated that MRM measurement and tryptic digestion steps each had average CVs of ∼2.7%. Because of the high purity of the peptide analytes enriched by antibody capture, the liquid chromatography step is minimized and in some cases eliminated altogether, enabling throughput levels consistent with requirements of large biomarker and clinical studies.
开发了用于人血浆胰蛋白酶消化及随后抗体介导的肽富集(SISCAPA方法)的高效机器人工作流程,目的是提高多重蛋白质生物标志物定量分析的精度和通量。首先,从经典方法简化了一种“仅添加”胰蛋白酶消化方案,无需样品净化,同时提高了重现性、可扩展性和成本。其次,开发了一些方法,以实现对人血浆中代表非常广泛浓度范围和分子量差异很大的蛋白质生物标志物的肽替代物进行多重富集和定量。在6天内对6个不同样品的每个样品进行6次重复测量的5种蛋白型肽的总工作流程变异系数(包括消化、SISCAPA肽富集和质谱分析这3个连续步骤),批内平均为3.4%,所有批次平均为4.3%。一项确定工作流程中变异来源的实验表明,MRM测量和胰蛋白酶消化步骤的平均变异系数均约为2.7%。由于通过抗体捕获富集的肽分析物纯度很高,液相色谱步骤被最小化,在某些情况下甚至完全消除,从而实现了与大型生物标志物和临床研究要求一致的通量水平。